Error: Could not add to watchlist. X

Synageva BioPharma Corp

+ Watchlist
GEVA:US
Acquired
GEVA:US was acquired by ALXN:US
USD
Volume
0
52Wk Range
60.19 - 239.20
Volume
0
52Wk Range
60.19 - 239.20
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-6.34
Market Cap (USD)
-
Shares Outstanding (m)
37.163
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Synageva BioPharma Corp. is a clinical stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need.
ADDRESS
128 Spring Street
Suite 520
Lexington, MA 02421
United States
PHONE
1-781-357-9900
  • Sanj K Patel
    President/CEO
  • Anthony G Quinn
    Exec VP/Chief Medical Officer
  • Carsten Boess
    Senior VP/CFO
  • Glen Williams
    Senior VP:Global Technical Ops
  • Matthew S Osborne
    VP:Investor Relations
Show More